MARKET

TRIB

TRIB

Trinity Biotech Plc
NASDAQ
0.6020
-0.0231
-3.70%
After Hours: 0.6099 +0.0079 +1.31% 16:53 05/22 EDT
OPEN
0.6200
PREV CLOSE
0.6251
HIGH
0.6200
LOW
0.6001
VOLUME
43.66K
TURNOVER
--
52 WEEK HIGH
3.440
52 WEEK LOW
0.5012
MARKET CAP
12.19M
P/E (TTM)
-0.2956
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TRIB last week (0511-0515)?
Weekly Report · 5d ago
Trinity Biotech files to sell 167.95M American depositary shares
TipRanks · 05/13 20:46
Weekly Report: what happened at TRIB last week (0504-0508)?
Weekly Report · 05/11 09:24
Trinity Biotech Names North America Commercial Head as Transformation Plan Starts to Lift Margins
TipRanks · 05/06 23:43
Trinity Biotech Q4 net loss widens to $17.5 million; revenue falls to $11.1 million
PUBT · 05/06 22:01
Weekly Report: what happened at TRIB last week (0427-0501)?
Weekly Report · 05/04 09:23
Trinity Biotech reports FY results
Seeking Alpha · 05/01 20:32
TRINITY BIOTECH PLC - Q4 2025 NET LOSS $17.5 MLN
Reuters · 05/01 13:31
More
About TRIB
Trinity Biotech plc is a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemical parameters in serum, plasma and whole blood, and the Company intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Its TrinScreen Human Immunodeficiency Virus (HIV) rapid point-of-care test is a high-quality, single-use immunoassays to aid in the diagnosis of HIV. The Uni-Gold range of rapid point-of-care test devices consist of high-quality, single-use immunoassays to aid in the diagnosis of HIV.

Webull offers Trinity Biotech PLC (ADR) stock information, including NASDAQ: TRIB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TRIB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TRIB stock methods without spending real money on the virtual paper trading platform.